Editas Medicine, Inc. (LON:0IFK)
2.319
0.00 (0.00%)
At close: Jun 18, 2025
Editas Medicine Employees
Editas Medicine had 246 employees as of December 31, 2024. The number of employees decreased by 19 or -7.17% compared to the previous year.
Employees
246
Change (1Y)
-19
Growth (1Y)
-7.17%
Revenue / Employee
112.75K GBP
Profits / Employee
-790.45K GBP
Market Cap
157.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Editas Medicine News
- 8 days ago - Wall Street Expects Editas Medicine to Soar 53%. Is It Time to Buy Now? - The Motley Fool
- 19 days ago - Editas Medicine Is Great. Here's Why You Shouldn't Buy It. - The Motley Fool
- 24 days ago - Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June - GlobeNewsWire
- 5 weeks ago - Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit - Seeking Alpha
- 6 weeks ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 7 weeks ago - Editas Medicine: A Cautionary Tale for Investors - The Motley Fool
- 7 weeks ago - Editas Medicine, Inc. (EDIT) BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June - GlobeNewsWire